abrdn Life Sciences Investors
HQL
49 hedge funds and large institutions have $57.5M invested in abrdn Life Sciences Investors in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 13 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.27% less ownership
Funds ownership: 23.3% → 17.03% (-6.3%)
9% less funds holding
Funds holding: 54 → 49 (-5)
22% less capital invested
Capital invested by funds: $73.9M → $57.5M (-$16.4M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.49M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.31M |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$678K |
| 4 |
DA
Doliver Advisors
Houston,
Texas
|
+$580K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$577K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
-$8.25M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.29M |
| 3 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$3.22M |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$2.25M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.95M |
HQL Hedge Fund Activity: Q3 2014 in Review
49 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2014, worth a combined $57.5M — down 22% from $73.9M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of HQL and 8 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 20 added.
The largest buyer was Morgan Stanley, adding an estimated $1.49M. The largest seller was Sit Investment Associates, exiting entirely with an estimated $8.25M sold.
- 49 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2014, down from 54 in Q2 2014.
- Funds reported $57.5M of abrdn Life Sciences Investors stock for Q3 2014, down 22% quarter-over-quarter.
- 8 funds opened new abrdn Life Sciences Investors positions in Q3 2014 and 13 closed out, a net change of -5 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2014 was Morgan Stanley, an estimated $1.49M added.
- The largest abrdn Life Sciences Investors seller in Q3 2014 was Sit Investment Associates, an estimated $8.25M sold.
Based on aggregated 13F filings for Q3 2014.